According to Reuters, Inspire pharmaceuticals marketed their FDA approved medication AzaSite, indicated to treat pink eye, for unapproved conditions such as blepharitis where it was not shown to be effective. This lead to doctors prescribing the medication for unapproved uses that may not have helped to...

According to Reuters, a new drug developed by Avalanche Biotechnologies Inc. has successfully completed a mid stage study. The drug, AVA-101, is used to treat patients with wet age-related macular degeneration and is effective in improving vision when compared to the placebo. Wet age-related macular...

A study from the NYU Langone Medical Center, according to an article published on CBS, has identified four types of bacteria more commonly found in contact lens wearers than non-contact wearers in an effort to explain why those who wear contacts get eye infections more frequently. Two of the four types,...